Yep, the train rolled back into the station and tickets aremmarked down 10%. I'm climbing aboard, but if it starts to slide backwards again, i'm hopping right off.
I'll admit it. I like biotechs and am a long mode investor. A week ago I would have bought on a pull back, which didn't come. So unless there is a temporary one (a late train), I bid all of you a Bon Voyage onward and upward on your northbound express. Here's to a good cause battling cancer and making some $$$ along the way! If anyone wants to diversify a small bit, I'm on a different northbound express that looks very promising and is a device (niche market) instead of a drug. Click my handle and you'll see. I wish I knew about CLVS about $40 earlier. Cheers and GLTA!
IMO, DNDN was the victim of FDA duplicity. It resulted in the FDA requiring another three years of study during which time the effectiveness data remained the same. Then the FDA approved Provenge. The outcome of this catastrophic decision was that many men with end stage prostate cancer were deprived of a treatment which would have significantly prolonged their lives, and Dendreon, facing competition not present three years before, economically could not succeed.
Not the case with Clovis Oncology.
while you waste your time saying this trash I am making money when these stocks run!
Silly me, I was waiting to see a pull back before taking a nibble. But it took off even higher. Very similar gain today as my flagship hold with InVivo Therapeutics.